172@29@17@106!~!172@29@0@53!~!|news|business|earnings|astrazeneca-pharma-india-q1-net-profit-declines-13-at-rs-18-63-crore-5676511.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Uncover the potential of active and passive investing on 6th October at 4pm. Register Now!
Last Updated : Aug 10, 2020 04:23 PM IST | Source: PTI

AstraZeneca Pharma India Q1 net profit declines 13% at Rs 18.63 crore

The company had posted a net profit of Rs 21.51 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a BSE filing.

PTI
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm AstraZeneca Pharma India on Monday reported a 13.38 percent decline in its net profit to Rs 18.63 crore for the quarter ended June.

The company had posted a net profit of Rs 21.51 crore for the corresponding period of the previous fiscal,  AstraZeneca Pharma India said in a BSE filing.

Revenue from operations stood at Rs 193.57 crore for the quarter under consideration. It was Rs 204.56 crore for the same period year ago, it added.

Close

The board of directors has declared an interim dividend of Rs 2 per equity share for the financial year 2020-21, the filing said.

Shares of AstraZeneca Pharma India were trading at Rs 3,381.65 per scrip on BSE, up 1.50 percent over previous close.
First Published on Aug 10, 2020 04:15 pm
Sections